(NASDAQ: SGHT) Sight Sciences's forecast annual revenue growth rate of 9.49% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.12%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.77%.
Sight Sciences's revenue in 2025 is $76,052,000.On average, 9 Wall Street analysts forecast SGHT's revenue for 2025 to be $4,160,053,539, with the lowest SGHT revenue forecast at $3,937,886,525, and the highest SGHT revenue forecast at $4,319,091,705. On average, 9 Wall Street analysts forecast SGHT's revenue for 2026 to be $4,662,070,624, with the lowest SGHT revenue forecast at $4,316,130,888, and the highest SGHT revenue forecast at $5,008,591,949.
In 2027, SGHT is forecast to generate $5,304,092,054 in revenue, with the lowest revenue forecast at $4,870,543,860 and the highest revenue forecast at $6,097,696,736.